Fig. 1From: Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)(Source: Collaborating Centre for Optimising Anti-malarial Therapy)Map of South Africa showing the three endemic provinces and three municipal districts in Mpumalanga ProvinceBack to article page